Combined Interventions for Severe Novel Coronavirus Disease (COVID-19): Experience from 350 Patients
Ting Guo,1– 3,* Qinxue Shen,1– 3,* Zhiguo Zhou,4 Jinhua Li,1– 3 Wei Guo,1– 3 Wenlong He,1– 3 Yunnian Wang,5 Zhi Xiang,6 Peng Huang,7 Nanyang Zeng,8 Qingwu Qin,1– 3 Ping Chen,1– 3 Hong Luo,1– 3 Hong Peng1– 3 1De...
Main Authors: | Guo T, Shen Q, Zhou Z, Li J, Guo W, He W, Wang Y, Xiang Z, Huang P, Zeng N, Qin Q, Chen P, Luo H, Peng H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-10-01
|
Series: | Infection and Drug Resistance |
Subjects: | |
Online Access: | https://www.dovepress.com/combined-interventions-for-severe-novel-coronavirus-disease-covid-19-e-peer-reviewed-article-IDR |
Similar Items
-
The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial
by: Naser Gharebaghi, et al.
Published: (2020-10-01) -
Effects of early corticosteroid use in patients with severe coronavirus disease 2019
by: Jong Hoon Hyun, et al.
Published: (2021-05-01) -
Detection of Severe Acute Respiratory Syndrome Coronavirus 2 RNA on Surfaces in Quarantine Rooms
by: Fa-Chun Jiang, et al.
Published: (2020-09-01) -
Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity
by: Glen Huang, et al.
Published: (2020-08-01) -
Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic
by: Nathan W. Furukawa, et al.
Published: (2020-07-01)